Clinical Trial Update: Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management

View source ↗

Summary

A completed clinical trial assessing awareness and perceptions of using high-sensitivity C-reactive protein (hsCRP) to identify systemic inflammation in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Chronic Kidney Disease
• Heart Failure

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Atherosclerotic Cardiovascular Disease, Heart Failure | Status: COMPLETED